Ceramide mediates covid-19 vascular injury and ards

Ended Project Grant Awarded Last action

Award ID
W81XWH2210243
Recipient
Awarding agency
Obligated
$1,593,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
New York, NY 10065, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Sloan-Kettering Institute For Cancer Research was awarded a $1,593,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) on September 30, 2022. The grant-funded project will investigate ceramide's role in mediating COVID-19 vascular injury and acute respiratory distress syndrome through basic, applied, and advanced biomedical research. Specifically, the Institute will conduct research to develop medical solutions for the battlefield by transforming healthcare for service members and the public. The period of performance for this award is from September 30, 2022 through September 29, 2026.

Quick answers

Who received award W81XWH2210243?

W81XWH2210243 was awarded to Sloan-Kettering Institute For Cancer Research by Medical Command (Department of the Army) on September 30, 2022.

How much is award W81XWH2210243 worth?

$1,593,000 has been obligated on W81XWH2210243.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login